Our team acted as lead counsel for a large long-term care company named as a defendant in a False Claims Act (FCA) qui tam action involving allegations of medically unnecessary services and improper billing. After conducting an internal investigation, we successfully advocated that the allegations lacked merit, thus leading the Department of Justice and a State Attorney General’s Office to decline to intervene in the matter.
Successful Declination of Qui Tam for Long-Term Care Company
You Also May Be Interested In:
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented CHS in its sale of Gulf Oaks Behavioral Hospital
Successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to HHS-OIG involving improper billing